FindTrial
Sign In

Metformin in patients with advanced non-small cell lung cancer chemotherapy effect and mechanism of research

Metformin in patients with advanced non-small cell lung cancer chemotherapy effect and mechanism of research

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONN-17014156
Enrollment
Unknown
Registered
2017-12-26
Start date
2017-12-31
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

Group 1:metformin+chemotherapy
Group 2:chemotherapy

Sponsors

Shihezi University Medical School First Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Aged 20 to 75 years old; (2) the ECOG function score 0 to 2 points;Have measurable lesions; (3) the basic normal important viscera function; (4) patients receiving cisplatin based chemotherapy regimens, and be able to comply with and follow-up research. (5) signed informed consent and agree to randomly into groups.

Exclusion criteria

Exclusion criteria: (1) the ECOG function score 3 points or above; (2) important viscera function is not normal; (3) do not accept platinum based chemotherapy regimens, and able to compliance and follow-up research; (4) does not sign the informed consent, not agree randomly into groups.

Design outcomes

Primary

MeasureTime frame
mTOR;—

Countries

China

Contacts

Public ContactPing Gong

Shihezi University Medical School First Affiliated Hospital

pingtengxiang@qq.com+86 18999536479

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026